ADVFN - Advanced Financial Network.
HOME» NYSE » M » MRK Stock Price » MRK Stock News

Merck Share News

 Merck & Co., Stock Price
MRK Stock Price
 Merck & Co., Stock Chart
MRK Stock Chart
 Merck & Co., Stock News
MRK Stock News
 Merck & Co., Company Information
MRK Company Information
 Merck & Co., Stock Trades
MRK Stock Trades

WSJ BLOG/Health: A.M Vitals: "Good" Cholesterol Drug Fails; Alzheimer's and Depression Linked

(This story has been posted on The Wall Street Journal Online's Health Blog at By Christopher Weaver Roche Drug to Raise 'Good' Cholesterol Fails (WSJ): The drug's failure in a large human trial spelled a setback for pharmaceutical companies that see an opportunity in medicines that seek to ward of heart disease by raising so-called "good" cholesterol. Competitors Merck and Eli Lilly said they remain confident in late-stage drugs in their pipelines that work similarly. Study Examines Depression and Aging Brain (WSJ): The onset of depression late in life can be an early warning of Alzheimer's disease and other dementia later, according to a new study of 13,535 Kaiser Permanente members. A Regime's Tight Grip on AIDS (New York Times): Cuba's AIDS rate is only one-sixth that of the U.S., thanks in part to aggressive tactics taken in the early years of the epidemic, such as forced quarantines for people who tested positive for HIV. F.D.A. Staff Raises Concerns About Arthritis Drug (New York Times): Documents released ahead of a Food and Drug Administration review Wednesday show regulators are concerned a new Pfizer treatment for rheumatoid arthritis raised concerns of significant side-effects. Court Dismisses Vets' Suit on Mental Health Care (San Francisco Chronicle): A San Francisco appeals court dismissed a five-year-old suit by veterans groups accusing the Department of Veterans Affairs of delaying needed mental health services. Drug-Defying Germs from India Speed Post-Antibiotic Era (Bloomberg): The widespread use of antibiotics in India is helping cultivate new breeds of drug-resistant bacteria bred from otherwise benign microorganisms. -For continuously updated news from The Wall Street Journal, see at

Stock News for Merck (MRK)
10/26/201617:25:04Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
10/26/201616:43:18Free Writing Prospectus - Filing Under Securities Act Rules 163/433...
10/26/201613:31:00Merck Prices EUR 1.0 Billion Debt Offering
10/26/201608:00:00Merck Highlights Ongoing Commitment to Fighting Infectious Diseases...
10/26/201606:05:47Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
10/26/201603:03:00Earnings Watch -- WSJ
10/25/201614:02:00Merck Revenue and Profit Rise on Cancer Drugs, Vaccines -- Update
10/25/201613:03:00Stocks Fall on Mixed Earnings Reports
10/25/201612:03:00Stocks Fall on Mixed Earnings Reports
10/25/201610:32:00Stocks Fall on Mixed Earnings Reports
10/25/201610:12:00Stocks Fall on Mixed Earnings Reports
10/25/201609:39:00Stocks Lifted by Upbeat Data, Earnings
10/25/201608:35:00Stocks Lifted by Upbeat Data, Earnings -- 2nd Update
10/25/201608:20:00Merck Profit Rises on Cancer Drugs, Vaccines
10/25/201608:13:00Merck Revenue and Profit Rise on Cancer Drugs, Vaccines
10/25/201606:50:52Current Report Filing (8-k)
10/25/201606:45:00Merck Announces Third-Quarter 2016 Financial Results
10/24/201621:40:00Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment
10/24/201620:50:00Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment
10/24/201618:04:00FDA Approves Merck’s KEYTRUDA® (pembrolizumab) in Metastatic NS...

Merck and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations